Campus Berlin-Buch has a new start-up center: The BerlinBioCube was ceremonially opened on October 11, 2023 in the presence of the Governing Mayor.
Continuation of its European growth course – Expansion of the services for pharmaceutical companies in Europe
One shot in the arm, and the whole body is protected. But how? For one thing, the immune system produces antibodies and cells that patrol the entire organism by traveling through the bloodstream. For another, as shown by a recent Charité –…
New plant will supply cell therapy products for late-stage clinical trials and future product launches / Supports clinical studies with BlueRock Therapeutics’ investigational cell therapy for Parkinson’s Disease bemdaneprocel (BRT-DA01) / New…
Berlin, Singapore, Allschwil 9-29-2023
Prof. Dr. Lars Schaade is the new President of the Robert Koch Institute. The 57-year-old physician had already been acting head of the Institute since 1 April, 2023.
Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study by the Gerhardt and De Smet labs published in “EMBO Molecular Medicine.”
Application Deadline: Friday, 3 November, 2023 at 6pm (CET)
A team of researchers has uncovered a previously unknown compensatory mechanism found in liver disease. If Kupffer cells (KCs), a specific kind of immune cells found in the liver, become impaired by tissue scarring, immune cells originating in the…
Eckert & Ziegler AG has been awarded the Pankow 2023 Training Prize for outstanding training quality. The award was presented yesterday at a celebration event by Berlin-Pankow District Mayor Dr. Cordelia Koch.